Lepu Biotech
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $316M
Investors
- 12
About Lepu Biotech
Established in 2018 and based in Shanghai, China, Lepu Biotech operates as a biopharmaceutical company focusing on the field of tumor treatment. The company has developed a pipeline of multiple oncology products, including eight clinical-stage candidates, three preclinical candidates and three clinical-stage candidates. Its pipeline covers the main nodes of the tumor immune cycle, such as immune desert tumors and inflammatory tumors.
Who invested in Lepu Biotech
12 investors across 2 rounds
See all investors in Lepu Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lepu Biotech
Who invested in Lepu Biotech?
Lepu Biotech has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lepu Biotech raised?
Lepu Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lepu Biotech last raise money?
Lepu Biotech's most recent round on record is a Series B, in Aug 2020.
What does Lepu Biotech do?
Established in 2018 and based in Shanghai, China, Lepu Biotech operates as a biopharmaceutical company focusing on the field of tumor treatment.
Where is Lepu Biotech headquartered?
Lepu Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like Lepu Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Lepu Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Lepu Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.